CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $626K invested in Can-Fite BioPharma in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

74% less capital invested

Capital invested by funds: $2.43M → $626K (-$1.8M)

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$54K
2
+$23K
3
+$15K
4
Bank of America
Bank of America
North Carolina
+$1K

Top Sellers

1
-$1.45M
2
-$155K
3
-$109K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$308K
2
$169K
3
$39K
4
$36K
5
$23K
6
$15K
7
$15K
8
$8K
9
$7K
10
$2K
11
$1.42K
12
$1K
13
$1K
14
$688
15
$354
16
–
17
–